Guidant Ancure insurer grievance
This article was originally published in The Gray Sheet
Executive Summary
Allianz Insurance Company files suit in Illinois DuPage County Circuit Court, "seeking to rescind or otherwise deny coverage" to Guidant, according to the manufacturer's quarterly filing Nov. 12. Guidant also discloses litigation in Indiana superior court against insurers, including Allianz, who seek to block coverage of Ancure AAA system, following subsidiary EndoVascular Technologies' $92 mil. settlement with the Justice department over adverse event reporting issues (1"The Gray Sheet" June 16, 2003, p. 4). During Q3, the firm reached agreements on 11 of 14 suits that predated the settlement. At least 15 civil suits remain, as well as a number of "class action complaints and shareholder derivative suits," according to the filing...
You may also be interested in...
Guidant/DoJ Probe Details Postmarket Reporting Meltdown With AAA Device
A settlement between Guidant and the Department of Justice over deficient medical device reporting of deaths and serious injuries, combined with public awareness of the lapses, sets the stage for closer scrutiny of MDR practices across the industry
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.